The document discusses various aspects of the human immune system and how it fights infections. It covers both innate and adaptive immunity, including cells like macrophages, dendritic cells, natural killer cells, B cells, and T cells. It also discusses the roles of antibodies, cytokines, and interferons. Specific mechanisms used to combat bacterial, viral, and intracellular infections are explained. Factors that influence immune response and methods of evading the immune system are also addressed.
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Immunity and vaccines for exam 3
1. SO....
HOW DO YOU FIGHT
BACK?
Monday, February 27, 2012
2. HOST FACTORS: WHAT YOU
DO TO FIGHT INFECTIONS
Immune System
Overview
Factors that affects the
immune status of the
host
age, nutrition, hygiene,
etc
Monday, February 27, 2012
26. EVASION BY BACTERIA
Some Bacteria Have Pili
Some Bacteria Secrete Adhesion Molecules (Bordetella pertussis)
Immune System Response To Attachment Is IgA
Prevents Attachment
Some Bacterial Evade IgA Thru Proteases That Decrease ½ Life Of
IgA
Ex. Haemophilus influenzae
Some Bacteria Avoid Phagocytosis By Surrounding Themselves In
A Polysaccharide Capsule. Ex. Streptococcus pneumoniae
Monday, February 27, 2012
27. OVERZEALOUS IMMUNE
SYSTEM NOT BENEFICIAL
Bacterial Septic Shock In Tuberculosis, MΦ Ingest MTB
But Cannot Digest It
Predominant Cytokines
Involved: IL-1 and TNF-α Eventually Burst - Releasing
Bacilli
Source: MΦ
MΦ And TH1 Cells Form
Intracellular Bacteria Cause
Granulomatous Lesion,
Granulomas
Containment+Destruction Of
Extensive Tissue Damage Healthy Tissue
Ex. Tuberculosis INF-γ and IL-12 Are Crucial In
Eliminating Pathogen
Monday, February 27, 2012
29. INFECTION BY VIRUSES
The Immune Response Against Virus Is Primarily Mediated Thru
Interferons
Double stranded RNA induces production of IFN
Main producers of IFNα and IFNβ are pDCs
TLR-3 (dsRNA); TLR-7 (ssRNA)
Interferons produce an anti-viral state
A state that inhibits viral replication
A state that inhibits viral infection
Monday, February 27, 2012
31. Antibody Protection Against Viruses
Antibodies Bind To Viral Surface Antigens
Protect against re-infection
Huge amounts of secretory IgA in lumen block viral attachment
Viral Entry Into Cells Is Mediated Thru Receptors
Influenza virus binds to sialic acid on glycoproteins
Rhinovirus binds to ICAMs
If Receptor Is Blocked, Infection Is Blocked
Oral Polio vaccine Relies On IgA Production
Monday, February 27, 2012
33. Antibody Protection Against
Viruses
Antibodies Are Efficient In Preventing Infection
Monday, February 27, 2012
34. Antibody Protection Against
Viruses
Antibodies Are Efficient In Preventing Infection
Once Infection Has Occurred, Only Cell Mediated
Immunity Can Eliminate Infected Cells
Monday, February 27, 2012
35. Antibody Protection Against
Viruses
Antibodies Are Efficient In Preventing Infection
Once Infection Has Occurred, Only Cell Mediated
Immunity Can Eliminate Infected Cells
Examples Of Cell Mediated Immunity
TH1, CTL Are the major participants
Monday, February 27, 2012
37. Antibody Protection Against
Viruses
TH1 Produce IFN-γ, IL-2,
and TNF-α
IL-2 expands CTL-P
IFN-γ induces antiviral
state
IL-2 and IFN-γ activate
NK cells (first line of
defense)
Monday, February 27, 2012
38. Antibody Protection Against
Viruses
TH1 Produce IFN-γ, IL-2, CTL (cytotoxic
and TNF-α lymphocytes)
IL-2 expands CTL-P Peaks 7-10 days post
infection
IFN-γ induces antiviral
state Eliminate virally infected
cells
IL-2 and IFN-γ activate
NK cells (first line of
defense)
Monday, February 27, 2012
54. IMMUNIZATION FOR INFANTS
Vaccine Reason for Immunization
BCG Given at the earliest possible age protects
against the possibility of infection from
family members
DPT Early start with DPT reduces chance of
severe pertussis
OPV Protection against polio increased the
earlier the OPV is given
Hepatitis B Early start of HBV vaccination reduces
chance of being infected and becoming a
carrier
Measles At least 80% of measles can be prevented
by immunization at this age
Monday, February 27, 2012
55. SCHEDULE
Age Diseases to be immunized against
Birth Tuberculosis
6 weeks DPT; Polio; HBV
10 weeks DPT; Polio; HBV
14 weeks DPT; Polio; HBV
9 months Measles
Monday, February 27, 2012
56. SIDE EFFECTS OF BCG
30 minutes wheal SIDE EFFECTS:
disappears 1. Koch’s phenomenon- an acute
2 weeks: a small red inflammatory reaction
tender swelling 10 cm appearing within 2-4 days of
appears vaccination
3 weeks: swelling 2. Deep abscess at vaccination site
becomes a small – due to subcutaneous or
abscess which then deeper injection (I & D)
ulcerates
3. Indolent ulceration- an ulcer
12 weeks: course from which persists after 12 weeks or
vaccination to healing & > 10cm deep (Tx –INH powder)
scarification
4. Lymph node enlargement
Monday, February 27, 2012
57. SIDE EFFECTS DPT
SIDE EFFECTS: Advice/ Management
Fever: many children
develop fever after Antipyretic or tepid sponge
injection , lasting only bath
one day; fever that
lasts more than 24 Reassure mother that
hours after a dose of
swelling needs no treatment
DPT is not due to the
and will disappear within
vaccine but to other
3-4 days
causes
Local Soreness: Pain or
swelling at injection
site
Monday, February 27, 2012
58. SIDE EFFECTS DPT
SIDE EFFECTS: Advice/ Management
Abscess: If this appears a
week or more after the Incision and drainage is
injection, it is due to necessary
wrong technique. Either
the vaccine was not If convulsions occur, give
injected deep enough or
proper management and
the needed was not
do not continue the
sterile
normal course
Convulsions: Very rare;
occurs more in >3
months; usually due to
pertussis component of
the vaccine
Monday, February 27, 2012
59. SIDE EFFECTS MEASLES VACCINE
SIDE EFFECTS: Advice/ Management
Fever and rash:
Children may develop Reassure the mother and
fever after 5-7 days advise antipyretic for
from the time of the child
vaccination
Fever lasts only from
1-3 days.
Sometimes a mild
rash appears
Monday, February 27, 2012
60. TETANUS TOXOID
Vaccine Minimum age/ Percent Duration of
protected
interval protection
As early as possible during
TT1 pregnancy
At least 4 weeks later * Infants born to the mother
TT2 80% protected from neonatal
tetanus; 3 years protection to
mother
At least 6 months later * Infants protected;
TT3 95% 5 years protection to mother
At least one year later * Infants protected;
TT4 99% 10 years protection to mother
At least one year later Lifetime protection for mother;
TT5 99% * all infants born to that mother
will be protected
Monday, February 27, 2012
61. VACCINES AND POLIO ERADICATION
EFFORTS (smallpox as model)
Parungao-Balolong 2011
Monday, February 27, 2012
62. MEASLES &
HERD
IMMUNITY
thepaltrysapien.com
Monday, February 27, 2012
63. EMERGING & RE-
EMERGING INFECTIONS
Monday, February 27, 2012
65. PUBLIC HEALTH PLANNING
& INTERVENTION
Disaster and Outbreak Preparedness
Accessibility to Intervention and Good Clinical Management
Environmental Sanitation and Hygiene
Research: Diagnostics, Therapy and Pathogenic Mechanisms
Surveillance and Prevention Control Programs
Health Promotion and Awareness Ads and Campaigns
Monday, February 27, 2012
66. END OF BIO 120
LECTURES
Monday, February 27, 2012